<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006835.ref022">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Hirai</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Sootome</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Nakatsuru</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Miyama</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Taguchi</surname>
   <given-names>S</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2010</year>) 
  <article-title>MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</article-title>. 
  <source>Molecular Cancer Therapeutics</source>
  <volume>9</volume>: 
  <fpage>1956</fpage>â€“
  <lpage>1967</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1535-7163.MCT-09-1012" xmlns:xlink="http://www.w3.org/1999/xlink">10.1158/1535-7163.MCT-09-1012</ext-link>
  </comment>
  <?supplied-pmid 20571069?>
  <pub-id pub-id-type="pmid">20571069</pub-id>
 </mixed-citation>
</ref>
